Analysis of the Cardiac Biomarker Diagnostics Market

Analysis of the Cardiac Biomarker Diagnostics Market

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

RELEASE DATE
30-Sep-2015
REGION
North America
Research Code: NF62-01-00-00-00
SKU: HC02515-NA-MR_16636

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02515-NA-MR_16636

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Competitive Landscape

Scope and Segmentation

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

  • Nanomix (POCT)
  • Critical Diagnostics (Lab-based)
  • CardioDx (POCT)

3 Big Predictions

Cardiac Diagnostics Industry Overview

Cardiac Biomarkers Diagnostics Overview

Market Background

Cardiac Diagnostics Overview

Testing Procedure

Factors Influencing Adoptability of Tests

Defining Healthcare Trends in the Future

New Market Opportunities

Solutions Provided by Top Companies

Important Partnerships—Cardiac Biomarker IVD Diagnostics

Emerging Biomarkers for MI and Clinical Strength

LDTs—Role in Cardiac Diagnostics

Other Emerging Biomarkers

Market Engineering Measurements

Revenue Forecast

Percent Revenue Breakdown by Segments

Segment Lifecycle Analysis

Market Share

Market Share Analysis

Overall Market Share Analysis

Top Competitors

Market Engineering Measurements

Revenue Forecast

POCT—Segment Share

Segment Share Analysis

Competitive Value Matrix

Top POCT Devices in the US Market

Competitive Product Analysis

Market Engineering Measurements

Revenue Forecast

Revenue Forecast by Disease Type

Growth Rate by Cardiac Disease

Product Portfolio

Pricing Trends and Forecast

Segment Share

Segment Share Analysis

Competitive Value Matrix

Cardiac Diagnostics Industry Overview

Partnership Trends—Medical Device Diagnostics

Industry Overview

Industry Overview by Application

New Market Opportunities

Imaging Technology—Role in Patient Continuum

Industry Overview

Cardiac Monitoring by Application

New Market Opportunities

ECG Technology—Role in Patient Continuum

Opportunities—Companion Diagnostics

Digital Health and Diagnostics Inter Convergence Model—Cardiac Diagnostics

Opportunity

3 Big Predictions

Legal Disclaimer

List of Others

Market Engineering Methodology

List of Figures
  • 1. Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
  • 2. Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
  • 3. Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
  • 4. Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011–2014
  • 5. Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US, 2014
  • 6. Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015–2021
  • 7. Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015–2021
  • 8. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • 9. Total Cardiac Biomarker Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
  • 10. Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
  • 11. Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
  • 12. POCT Segment: Market Engineering Measurements, US, 2014
  • 13. POCT Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • 14. POCT Segment: Top 10 Products, US, 2014
  • 15. Lab-based Tests Segment: Market Engineering Measurements, US, 2014
  • 16. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • 17. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • 18. Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011–2014
  • 19. Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • 20. Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
  • 21. Total Cardiac Diagnostics Industry: ECG, US, 2014
  • 22. Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
  • 23. Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013–2015
List of Charts
  • 1. Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
  • 2. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • 3. Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
  • 4. Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
  • 5. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
  • 6. Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
  • 7. Total Cardiac Biomarker Diagnostics Market: Adoptability of Biomarker Tests, US, 2014
  • 8. Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
  • 9. Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
  • 10. Cardiac Diagnostics Prevalence Rate, US, 2009–2020
  • 11. Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011–2021
  • 12. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
  • 13. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
  • 14. Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
  • 15. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
  • 16. POCT Segment: Revenue Forecast, US, 2011–2021
  • 17. POCT Segment: Percent Revenue Breakdown, US, 2014
  • 18. POCT Segment: Competitive Analysis, US, 2014
  • 19. POCT Segment: Product Analysis, US, 2014
  • 20. Lab-based Tests Segment: Revenue Forecast, US, 2011–2021
  • 21. Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011–2021
  • 22. Lab-Based Tests Segment: Growth Rate by Cardiac Disease, US, 2011–2021
  • 23. Lab-based Tests Segment: Product Analysis, US, 2014
  • 24. Lab-based Tests Segment: Average Price, US, 2009–2021
  • 25. Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
  • 26. Lab-based Tests Segment: Competitive Analysis, US, 2014
  • 27. Total Cardiac Diagnostics Market: Industry Overview, US, 2014
  • 28. Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
  • 29. Total Cardiac Diagnostics Market: Patient Continuum, US, 2014
  • 30. Total Cardiac Monitoring Market: Market Segmentation, US, 2014
  • 31. Total Cardiac Monitoring Industry: Patient Continuum, US, 2014
  • 32. Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013–2015
Related Research
The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ || Competitive Landscape~ || Scope and Segmentation~ || Market Engineering Measurements~ || CEO’s Perspective~ || Key Companies to Watch~ ||| Nanomix (POCT)~ ||| Critical Diagnostics (Lab-based)~ ||| CardioDx (POCT)~ || 3 Big Predictions~ | Market Overview~ || Cardiac Diagnostics Industry Overview~ || Cardiac Biomarkers Diagnostics Overview~ || Market Background~ ||| Prevalence Rate~ || Cardiac Diagnostics Overview~ || Testing Procedure~ || Factors Influencing Adoptability of Tests~ || Defining Healthcare Trends in the Future~ | Competitive Playbook~ || New Market Opportunities~ || Solutions Provided by Top Companies~ || Important Partnerships—Cardiac Biomarker IVD Diagnostics~ || Emerging Biomarkers for MI and Clinical Strength~ | Emerging Biomarkers~ || LDTs—Role in Cardiac Diagnostics~ || Other Emerging Biomarkers~ | Driver and Restraints—Total Cardiac Biomarker Diagnostics Market~ || Market Drivers~ ||| A high prevalence rates~ ||| The increasing use of biomarkers~ ||| The HF market segment is expected to gain popularity~ ||| There is a focus on precision medicine~ || Market Restraints~ ||| Reimbursement cuts~ ||| Laboratory consolidation~ ||| A tougher regulatory environment~ ||| Increasing competition from other technologies, including mobile diagnosis~ | Forecasts and Trends—Total Cardiac Biomarker Diagnostics Market~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Breakdown by Segments~ || Segment Lifecycle Analysis~ | Competitive Environment~ || Market Share~ || Market Share Analysis~ || Overall Market Share Analysis~ || Top Competitors~ ||| Alere~ ||| Roche Diagnostics~ ||| Siemens Healthcare~ ||| Abbott~ ||| Beckman Coulter~ | POCT Segment Analysis~ || Market Engineering Measurements~ || Revenue Forecast~ || POCT—Segment Share~ || Segment Share Analysis~ || Competitive Value Matrix~ || Top POCT Devices in the US Market~ || Competitive Product Analysis~ | Lab-based Segment Analysis~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Forecast by Disease Type~ || Growth Rate by Cardiac Disease~ || Product Portfolio~ || Pricing Trends and Forecast~ || Segment Share~ || Segment Share Analysis~ || Competitive Value Matrix~ | The Full Picture—Cardiac Diagnostics Industry Overview~ || Cardiac Diagnostics Industry Overview~ || Partnership Trends—Medical Device Diagnostics~ | Cardiac Imaging Diagnostics~ || Industry Overview~ ||| Industry Overview by Application~ ||| OEMs~ ||| Healthcare Providers~ ||| Regulatory Bodies~ || Industry Overview by Application~ ||| Cardiac Imaging and Monitoring~ |||| Interventional Cardiology~ |||| Monitoring~ |||| Imaging and Diagnostics~ || New Market Opportunities~ || Imaging Technology—Role in Patient Continuum~ | ECG in Cardiac Diagnostics~ || Industry Overview~ || Cardiac Monitoring by Application~ || New Market Opportunities~ || ECG Technology—Role in Patient Continuum~ | Opportunities~ || Opportunities—Companion Diagnostics~ || Digital Health and Diagnostics Inter Convergence Model—Cardiac Diagnostics~ || Opportunity~ ||| Convergence of Imaging and IVD~ ||| Key Companies to Watch~ | The Last Word~ || 3 Big Predictions~ || Legal Disclaimer~ | Appendix~ || List of Others~ || Market Engineering Methodology~
List of Charts and Figures 1. Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024~ 2. Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014~ 3. Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014~ 4. Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011–2014~ 5. Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US, 2014~ 6. Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015–2021~ 7. Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015–2021~ 8. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014~ 9. Total Cardiac Biomarker Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014~ 10. Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014~ 11. Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014~ 12. POCT Segment: Market Engineering Measurements, US, 2014~ 13. POCT Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014~ 14. POCT Segment: Top 10 Products, US, 2014~ 15. Lab-based Tests Segment: Market Engineering Measurements, US, 2014~ 16. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014~ 17. Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014~ 18. Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011–2014~ 19. Total Cardiac Diagnostics Industry: Industry Overview, US, 2014~ 20. Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014~ 21. Total Cardiac Diagnostics Industry: ECG, US, 2014~ 22. Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014~ 23. Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013–2015~| 1. Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014~ 2. Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014~ 3. Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014~ 4. Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014~ 5. Cardiac Diagnostics Prevalence Rate, US, 2009–2020~ 6. Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014~ 7. Total Cardiac Biomarker Diagnostics Market: Adoptability of Biomarker Tests, US, 2014~ 8. Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014~ 9. Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014~ 10. Cardiac Diagnostics Prevalence Rate, US, 2009–2020~ 11. Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011–2021~ 12. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014~ 13. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021~ 14. Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014~ 15. Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014~ 16. POCT Segment: Revenue Forecast, US, 2011–2021~ 17. POCT Segment: Percent Revenue Breakdown, US, 2014~ 18. POCT Segment: Competitive Analysis, US, 2014~ 19. POCT Segment: Product Analysis, US, 2014~ 20. Lab-based Tests Segment: Revenue Forecast, US, 2011–2021~ 21. Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011–2021~ 22. Lab-Based Tests Segment: Growth Rate by Cardiac Disease, US, 2011–2021~ 23. Lab-based Tests Segment: Product Analysis, US, 2014~ 24. Lab-based Tests Segment: Average Price, US, 2009–2021~ 25. Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014~ 26. Lab-based Tests Segment: Competitive Analysis, US, 2014~ 27. Total Cardiac Diagnostics Market: Industry Overview, US, 2014~ 28. Total Cardiac Diagnostics Industry: Overview by Application, US, 2014~ 29. Total Cardiac Diagnostics Market: Patient Continuum, US, 2014~ 30. Total Cardiac Monitoring Market: Market Segmentation, US, 2014~ 31. Total Cardiac Monitoring Industry: Patient Continuum, US, 2014~ 32. Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013–2015~
Author Aish Vivekanadan
Industries Healthcare
WIP Number NF62-01-00-00-00
Is Prebook No